WaveSense Signs UK, Ireland Distribution Deal With Pisces Scientific | GenomeWeb

NEW YORK (GenomeWeb) – WaveSense announced today that has signed a strategic marketing agreement with diagnostics distributor Pisces Scientific for its recently CE-IVD marked rare cell enrichment platform and bead-based isolation technology.

Under the terms of the deal, Pisces will market and sell WaveSense products — including the company's EpiSep direct-to-slide enrichment platform and its proprietary paramagnetic bead technology for the selective isolation of cells that express CD138 — to hematology-oncology cytogenetics labs in Ireland and the UK.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.